NCT06125262View on ClinicalTrials.gov

Trajectory Analysis of NLR and Its Association With Efficacy of Immunochemotherapy in ESCC.

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

July 31, 2025

Conditions

Esophageal Squamous Cell CarcinomaImmunotherapyChemotherapy

Trial Locations (1)

510080

RECRUITING

Guangdong Provincial People's Hospital, Guangzhou

All Listed Sponsors

lead

Guangdong Provincial People's Hospital

OTHER